14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $32.75 $38.21 Friday, 3rd May 2024 KYMR stock ended at $37.40. This is 3.03% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.98% from a day low at $36.06 to a day high of $38.21.
90 days $31.83 $45.31
52 weeks $9.60 $45.31

Historical Kymera Therapeutics Inc. prices

Date Open High Low Close Volume
May 03, 2024 $37.35 $38.21 $36.06 $37.40 529 366
May 02, 2024 $36.17 $36.83 $35.06 $36.30 488 748
May 01, 2024 $33.57 $37.80 $33.52 $36.24 624 226
Apr 30, 2024 $34.13 $34.44 $33.55 $33.62 462 720
Apr 29, 2024 $33.75 $34.71 $33.67 $34.66 428 515
Apr 26, 2024 $33.75 $34.13 $33.22 $33.37 447 088
Apr 25, 2024 $34.28 $34.29 $32.75 $33.35 773 958
Apr 24, 2024 $35.66 $36.26 $34.67 $35.21 335 676
Apr 23, 2024 $34.49 $37.01 $34.49 $35.71 437 029
Apr 22, 2024 $34.87 $35.37 $33.85 $34.35 417 171
Apr 19, 2024 $34.98 $35.53 $33.35 $33.97 627 420
Apr 18, 2024 $33.67 $35.57 $33.67 $35.12 605 032
Apr 17, 2024 $34.39 $34.41 $33.17 $33.76 433 665
Apr 16, 2024 $33.78 $34.76 $33.58 $33.93 481 224
Apr 15, 2024 $35.81 $35.82 $34.24 $34.39 528 586
Apr 12, 2024 $36.81 $36.89 $34.75 $35.58 598 100
Apr 11, 2024 $35.61 $37.32 $35.43 $37.21 469 124
Apr 10, 2024 $35.72 $36.43 $35.08 $35.33 655 350
Apr 09, 2024 $36.53 $37.64 $35.98 $37.61 486 621
Apr 08, 2024 $36.70 $37.18 $35.96 $36.37 296 257
Apr 05, 2024 $36.07 $37.16 $35.31 $36.40 424 433
Apr 04, 2024 $37.42 $38.02 $36.04 $36.24 471 399
Apr 03, 2024 $37.27 $38.09 $36.59 $37.13 591 838
Apr 02, 2024 $38.26 $38.66 $36.76 $37.64 532 369
Apr 01, 2024 $40.34 $40.55 $38.21 $39.42 516 739
Click to get the best stock tips daily for free!

About Kymera Therapeutics Inc.

Kymera Therapeutics. Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation ... KYMR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT